ArticleScientific reports2026
Imidacloprid induces hepatorenal toxicity in male albino rats via oxidative, immune inflammatory, and proliferative effects: a 90-day study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Imidacloprid (IM), a systemic neonicotinoid pesticide, is widely used globally due to its high effectiveness against a broad range of insects at minimal application rates. The current study aimed to examine how this insecticide can induce oxidative stress, disrupt the inflammatory process, and influence cellular proliferation in hepatorenal tissues, even at low doses. Thirty adult male albino rats were divided into five groups (n = 6). The first group served as the control, while the other four groups received IM at 0.3, 3, 30, and 60 ppm, respectively, over 90 days through drinking water. Results revealed significant histopathological changes in the liver and kidneys of rats exposed at all doses. A notable increase in hepatorenal markers, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), urea, and creatinine levels, and a slight decrease in total serum protein (TP) were observed. There was a significant rise in malondialdehyde (MDA) levels, along with increased production of pro-inflammatory cytokines, including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and NOD-like receptor protein-3 (NLRP3). This was accompanied by strong immunopositivity of proliferating cell nuclear antigen (PCNA) and Ki-67 protein expression, while adipocyte-specific adhesion molecule (ASAM) levels showed insignificant changes. The study concludes that IM can induce hepatorenal damage accompanied by lipid peroxidation, elevated inflammatory mediators, and altered proliferative indicators. The effects were generally more apparent at higher dosages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.